Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

Screenetics contract win

18 Nov 2013 07:00

RNS Number : 2240T
Ultrasis PLC
18 November 2013
Β 

Ultrasis plc

("Ultrasis" or the "Company")

Β Ultrasis Group acquisition, Screenetics, scores contract wins

Ultrasis announces that its recently-acquired screening and wellbeing subsidiary, Screenetics UK Limited ("Screenetics"), has won three new contracts with customers spanning the public and private sectors. The value of the contracts is an estimated Β£2 million per annum. The revenues are partly conditional on performance, but, based on past experience, Screenetics is confident of fulfilling the contract criteria.

Ultrasis acquired Screenetics on the 4th October 2013 as part of its strategy to broaden the range of products and services it provides and to enable it to become a provider of wellbeing, health and social care services.

The contracts relate to the provision of:

Β· 9,500 flu vaccinations (currently being delivered, one year contract);

Β· health screenings as part of a salary sacrifice scheme to a large public sector body (commences February 2014 ,three year contract); and

Β· employee screening to a large UK corporate company (commences spring 2014, initially one year contract).

"This is positive news for both the Screenetics team and for Ultrasis," said John Smith, Ultrasis' Chief Executive. "We are delighted to have secured these significant contracts so soon after the acquisition and believe Screenetics is now well positioned to secure further contract gains. The strength of Screentics in the wellness and screening market is their absolute focus on quality customer service and in delivering the very best experience for the individual using their services".

Β Kevin Hollick, Screenetics' Managing Director, said: "We have been strengthened by becoming part of the Ultrasis Group and it is encouraging to see these contracts come to fruition, I am confident that 2014 is going to be a significant year of growth for the Screenetics business. We are planning for the volume of health assessments we provide to quadruple in the next 12 months and these contracts put us well on the way to exceeding our expectations".

He added "2014 also sees the introduction of our first mobile health assessment vehicle which will initially be used to deliver a nationwide road show for a large corporate customer to promote wellbeing in the workplace".

Β 

Β 

Ends

Β 

Editor's notes:

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.

For more information about Ultrasis please visit www.ultrasis.comΒ 

ScreeneticsΒ is a leading supplier of Health and Wellbeing Services to the Corporate Sector, Private Organisations and the general public. Screenetics has secured a reputation for delivering services that focus on customer care of the highest quality. Based in Milton Keynes and providing a national service it became part of the Ultrasis Group in October 2013.

For more information about Sceenetics please visit www.screenetics.com

Β 

Enquiries:

For all enquiries relating to Ultrasis please contact

Β Ultrasis plc

Β 

John Smith, Chief Executive

Tel: +44 (0) 20 7535 2050

Β 

Β 

Β 

finnCap Limited

Β 

Geoff Nash/Simon Hicks

Tel: +44 (0) 20 7220 0500

Β 

Β 

Β 

JBP Public Relations

Β 

Chris Lawrance

Tel: +44 (0) 11 7907 3400

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CNTBRBDBUUBBGXR
Date   Source Headline
1st Oct 20137:00 amRNSNew Customer Win
16th Sep 20139:30 amRNSBeating the Blues Research at The White House
13th Sep 20137:00 amRNSBoard Changes
9th Sep 20139:04 amRNSAcquisition & Issue of Equity
6th Sep 20137:00 amRNSDirectorate Change
2nd Sep 20132:50 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSNew corporate website
20th Aug 20137:00 amRNSContract Win
2nd Aug 201311:45 amRNSFurther US Success for Beating the Blues
1st Aug 20135:03 pmRNSIssue of Equity and Directors' Dealings
1st Aug 20137:00 amRNSNew partnership to address NHS market
5th Jul 20131:00 pmRNSIssue of Equity
17th Jun 20137:52 amRNSUltrasis US Joint Venture Success
14th Jun 20137:00 amRNSHolding(s) in Company
7th Jun 20137:00 amRNSDirectorate Change
21st May 20137:00 amRNSStrategic partnership with US Joint Venture
1st May 20133:40 pmRNSIssue of Equity and Block listing update
2nd Apr 201312:00 pmRNSChange of Adviser
20th Mar 20137:00 amRNSInterim Results
14th Feb 20137:00 amRNSCompletion of fundraising and total voting rights
4th Feb 20132:32 pmRNSIssue of Shares under Share Incentive Plan
30th Jan 20133:45 pmRNSResult of AGM
29th Jan 20137:00 amRNSProposed Financing Arrangements & Director Change
7th Jan 20137:00 amRNSAnnual Report & Notice of AGM
16th Nov 20127:00 amRNSFinal Results
5th Nov 20127:00 amRNSFurther Research Success
5th Nov 20127:00 amRNSIssue of Shares & Blocklisting Update
1st Nov 20122:15 pmRNSHolding(s) in Company
1st Nov 20127:00 amRNSNew Contract Win
2nd Aug 20128:10 amRNSCost Control and Share Incentive Plan
31st Jul 20127:00 amRNSNew customer for US Joint Venture
11th Jul 20127:00 amRNSChina Hospital Partnership
12th Jun 20122:28 pmRNSHolding(s) in Company
2nd May 20127:00 amRNSIssue of Shares & Block Listing Update
30th Apr 201211:00 amRNSGrant for BtB US Trials
24th Apr 20129:40 amRNSHolding(s) in Company
4th Apr 20127:00 amRNSInterim Results
7th Feb 201212:45 pmRNSHolding(s) in Company
1st Feb 201212:51 pmRNSIssue of Shares under Share Incentive Plan
27th Jan 20127:00 amRNSResult of AGM
26th Jan 20127:00 amRNSFirst customer for US version of Beating the Blues
25th Jan 20127:00 amRNSHolding(s) in Company
16th Jan 20127:00 amRNSCommencement of Pilot Project
9th Jan 20121:00 pmRNSCanadian Pilot
20th Dec 201111:00 amRNSAnnual Report and Notice of Annual General Meeting
8th Nov 20117:01 amRNSBlocklisting Six Monthly Update
8th Nov 20117:00 amRNSFinal Results
25th Oct 201111:00 amRNSUltrasis launches Share Incentive Plan
10th Oct 20117:00 amRNSNew Partnership
6th Oct 201112:00 pmRNSLaunch of US version of Beating the Blues

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.